The winner of the German Non-Fiction Prize 2025 is Ulli Lust, for her work “Die Frau als Mensch. Am Anfang der Geschichte” (“Woman as Human. At the Dawn of History”) (Reprodukt).
Statement from the jury:
“The strong woman as a human being. In her informed and imaginative non-fiction book on the origins of humanity – between evolution and culture – Ulli Lust reveals how the role of women in human history has remained largely invisible. A fundamental r
Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines.
Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company s newly established Cambridge location, where he will establish a group of world-class biomedical talent as the company advances its work translating AI-driven drug discovery
Aduna (https://adunaglobal.com/), the global aggregator of network APIs, and NTT DOCOMO, Inc., one of Japan s leading mobile operators with over 91 million subscribers, today announced an intention to enter a strategic collaboration under a Memorandum of Understanding to bring network APIs to developers and enterprises across the region. This joint effort marks a significant milestone in Aduna s Asia-Pacific expansion and reflects a shared commitment to advancing programmable, secure, and intero
MedHub-AI (http://www.medhub-ai.com/), pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market. This partnership marks a new era in coronary physiology assessment where AI technology delivers superior confidence, reproducibility, and clinical accuracy compared to conventional 3D FFR methodologies.
– Stan Miller appointed CEO to lead United Group as it strategically refocuses its business on EU markets following successful sale of non-EU operations
– Together with Stan, Libor Voncina appointed deputy CEO, each bring decades of industry experience and proven track record in the European telecoms and media sectors
– Founder Dragan Šolak and CEO Victoriya Boklag to step down from their current positions
United Group BV ("UG"), the leading telecommunications and media provi
Wiremind, a leading provider of innovative solutions for the transportation and ticketing industry, today announced the launch of its PAXONE OSDM Sandbox, an open environment for testing and validating OSDM-based ticketing and distribution management solutions. This launch positions Wiremind as the fourth major provider to offer an OSDM Sandbox, joining other providers in supporting industry-wide adoption of open, standardized data management.
The Open Sales and Distribution Model (OSDM) is an
This new feature will turn the operational database into a powerful native AI engine, responding to the growing demand for engineering teams to deliver GenAI capabilities.
RavenDB, a high-performance NoSQL document database trusted by developers and enterprises worldwide, today announced the launch of its new feature, bringing native Generative AI (GenAI) capabilities directly into its core database engine, marking a new chapter in how data and intelligence converge to drive real-time innovatio
– Aviva platform continues development of innovative technology to support advisers.
– The latest innovation, the Aviva Analytics tool, is now live with selected adviser firms, providing powerful MI and reporting capabilities.
– This latest innovation is underpinned by the scale and reliability of the Aviva platform, which executes around 350,000 automated trades every day.
Following the launch of its Onshore Bond on Adviser Platform last month, Aviva is pleased to announce its latest technolo
BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic science to clinical trials.
BIAL will be presenting the ACTIVATE study, a Phase II trial evaluating the effic
ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.
This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies.
